GLS-010, a novel anti-PD-1 mAb in Chinese patients with relapsed or refractory classical Hodgkin's lymphoma: Preliminary result of a phase II clinical trial
Song Yuqin,Zhu Jun,Lin Ningning,et al.GLS-010, a novel anti-PD-1 mAb in Chinese patients with relapsed or refractory classical Hodgkin's lymphoma: Preliminary result of a phase II clinical trial[J].JOURNAL OF CLINICAL ONCOLOGY.2019,37(15):doi:10.1200/JCO.2019.37.15_suppl.e14072.
APA：
Song, Yuqin,Zhu, Jun,Lin, Ningning,Zhang, Chen,Zhang, Mingzhi...&Meng, Haijin.(2019).GLS-010, a novel anti-PD-1 mAb in Chinese patients with relapsed or refractory classical Hodgkin's lymphoma: Preliminary result of a phase II clinical trial.JOURNAL OF CLINICAL ONCOLOGY,37,(15)
MLA：
Song, Yuqin,et al."GLS-010, a novel anti-PD-1 mAb in Chinese patients with relapsed or refractory classical Hodgkin's lymphoma: Preliminary result of a phase II clinical trial".JOURNAL OF CLINICAL ONCOLOGY 37..15(2019)
医学